Bill > HB06810

This bill proposes to amend existing statutes to require healthcare organizations participating in the 340B Drug Pricing Program to submit periodic reports detailing how they are using drug discount savings to benefit patients. The 340B program, named after a section of the Public Health Service Act, allows certain healthcare providers (known as "covered entities") to purchase prescription drugs at significantly reduced prices. Under this proposed legislation, these healthcare entities would be required to file detailed reports explaining how they are utilizing the cost savings from these discounts to improve patient care. If these organizations fail to submit such reports, they would become ineligible for Medicaid reimbursement, creating a strong incentive for transparency. The bill aims to ensure that the financial benefits of the drug discount program are directly translated into patient benefits, rather than simply being absorbed as additional organizational revenue.

Health and Social Services

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06810&which_year=2025